The increasing use of automatic contrast injection systems raises concerns about potential septic risks to patients. Our study aimed to evaluate the efficacy of a newly developed replaceable patient-delivery system designed to allow multiple uses without compromising patient safety.

Our findings demonstrate that the tested Transflux® delivery system is both convenient and safe, offering a promising solution for reducing septic risks while maintaining efficiency in multiple-use scenarios.